Findings identify post-translational MHC-I trafficking as a previously underappreciated regulatory layer linking inflammatory signaling to the canonical IFN-γ–MHC-I axis and reveal an SQSTM1-dependent mechanism controlling MHC-I surface availability under immune-inflamed tumor conditions.
Macrophages function as professional antigen-presenting cells that integrate inflammatory signals with metabolic reprogramming to shape immune responses. Itaconate, an immunometabolite derived from ACOD1/IRG1 activity in activated macrophages, has been implicated in the regulation of inflammatory responses, yet its rol...
Zhi-Ying Zhou, Yi-Xiu Ni, Shan-Shan Huang et al.· Journal of Immunology· 0 citations
Immunotherapy has revolutionized cancer treatment. One of the key mediators of tumor-immune
interactions is the major histocompatibility complex (MHC) class I (MHC-I), a protein expressed on the
surface of cancer cells to present tumor-derived antigens to CD8+ T cells, and loss or downregulation
of MHC-I contributes to...
Max Chi· American Journal of Student...· 0 citations
This Mini Review examines tumor-intrinsic IFN-γ-associated immunity at three functional checkpoints: proximal IFN-γ sensing and signal transduction, chemokine-mediated effector-cell recruitment, and antigen-presentation-dependent tumor recognition.
Jing-Jing Lu, Yi-Chun Jiang, Yan-Shan Jin et al.· Frontiers in Immunology· 0 citations
Abstract CD163+ tumor-associated macrophages (TAM) are associated with poor response to immunochemotherapy in patients with diffuse large B-cell lymphoma and comprise a significant proportion of the tumor microenvironment (TME). Targeting these TAMs to reverse immunosuppression is an attractive approach for improving t...
J. Longley, L. Dahal, Russell B. Foxall et al.· Cancer Research Communicatio...· 0 citations
Radiation-induced lung injury (RILI) is a common dose-limiting toxicity after radiotherapy for lung cancer, but the immunological mechanisms contributing to RILI pathogenesis remain poorly understood. Here we analyze a RILI mouse model using high-dose, restricted-field irradiation to the left lung. Flow cytometry and c...
Jaeho Kim, Hai-Qing Li, R. Mannan et al.· Nature Communications· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive tumor microenvironment (TME) and poor prognosis. Although major histocompatibility complex class II (MHC-II) is typically expressed by professional antigen-presenting cells, its regulation and significance in malignant PDAC cells remain un...
Can-Ping Chen, Yi Zhang, Xi Li et al.· Cancer immunology research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.